Purple Innovation's biggest risks in the FY2024 10-K
- Purple faces substantial liquidity pressure, recurring operating losses, and significant debt obligations held largely by controlling stockholder Coliseum Capital.
The risks most specific to Purple Innovation
- Risks Relating to Our Business and Our Operations
Our indebtedness, related covenants, and certain prepayment obligations, including make-whole payments, could limit operational and financial flexibility and adversely affect our business if we breach such covenants or default on such indebtedness
Refinancing agreements with Coliseum Capital impose strict covenants and prepayment make-whole obligations that could restrict our operational flexibility.
- Risks Relating to Our Business and Our Operations
We may need additional funds to execute our business plan, maintain our liquidity, repay our debt and fund our operations. We may not be able to obtain such funds on acceptable terms or at all
We experienced negative operating cash flow of $18.0 million in 2024 and $54.7 million in 2023, creating ongoing liquidity needs.
- Risks Relating to Our Business and Our Operations
Under the Amended and Restated Credit Agreement, we can request additional loans, but the Lenders may deny requests, limiting our access to future funds and adversely affecting our liquidity, financial condition and results of operations
Future financing may dilute existing stockholders, evidenced by warrants for 20.0 million common shares issued to lenders on January 23, 2024.
- Risks Relating to Our Business and Our Operations
We may not realize all the intended benefits of our Restructuring Plan and other cost-saving initiatives, which could adversely affect our results of operations and our financial condition
Our Restructuring Plan to consolidate Utah manufacturing into McDonough, Georgia may incur higher costs and fail to deliver expected savings.
- Risks Relating to Our Business and Our Operations
Coliseum Capital Management, LLC is our largest stockholder and Lender, and exercises substantial control over our Board composition, management team members and strategies
Coliseum Capital beneficially owns 58.5 million shares, including warrant shares, giving them substantial control over our Board and management strategies.
- Risks Relating to Our Business and Our Operations
We have engaged in significant related-party transactions with Coliseum and other parties that may give rise to conflicts of interest or otherwise adversely affect our results of operations and the value of our business
Related-party transactions with Coliseum and other affiliates involving $80.0 million in loans and warrants may create conflicts of interest.
- Risks Relating to Our Business and Our Operations
Changes in economic conditions, including the housing market and tariffs, have or will adversely affect our business, results of operations and financial condition
Macroeconomic weakness in the housing market and high mortgage interest rates have negatively impacted consumer demand for our mattresses.
- Risks Relating to our Common Stock
Significant payment obligations under our Tax Receivable Agreement are accelerated upon a change of control and may discourage the potential acquisition of our Company and adversely affect any potential control premium payable for shares of our Common Stock
Our Tax Receivable Agreement requires us to pay founders 80% of certain tax benefits, which accelerates upon a change of control.
- Risks Relating to our Common Stock
Obligations under the Tax Receivable Agreement could materially adversely affect our future cash flow if we become profitable and begin paying income taxes. Payments under the Tax Receivable Agreement may be accelerated or significantly exceed the actual benefits we realize
Our preliminary estimated liability under the Tax Receivable Agreement was $169.0 million as of December 31, 2024.
- Risks Relating to our Common Stock
The NOL Protective Charter Amendment and the NOL Rights Plan may have an anti-takeover effect
The NOL Protective Charter Amendment and Rights Plan restrict stockholders from accumulating more than 4.9% of our common stock, creating an anti-takeover effect.
All 39 risk factors
Headings as the filing states them, in filing order.
Risks Relating to Our Business and Our Operations
- 01Our indebtedness, related covenants, and certain prepayment obligations, including make-whole payments, could limit operational and financial flexibility and adversely affect our business if we breach such covenants or default on such indebtedness
- 02We may need additional funds to execute our business plan, maintain our liquidity, repay our debt and fund our operations. We may not be able to obtain such funds on acceptable terms or at all
- 03Under the Amended and Restated Credit Agreement, we can request additional loans, but the Lenders may deny requests, limiting our access to future funds and adversely affecting our liquidity, financial condition and results of operations
- 04We may not realize all the intended benefits of our Restructuring Plan and other cost-saving initiatives, which could adversely affect our results of operations and our financial condition
- 05We have in the past experienced and may in the future experience significant fluctuations in our results of operations, which could make our future results of operations difficult to predict or cause our results of operations to fall below analysts’ and investors’ expectations
- 06Coliseum Capital Management, LLC is our largest stockholder and Lender, and exercises substantial control over our Board composition, management team members and strategies
- 07We have engaged in significant related-party transactions with Coliseum and other parties that may give rise to conflicts of interest or otherwise adversely affect our results of operations and the value of our business
- 08Our preliminary exploration of potential strategic alternatives may not be successful, which may adversely affect our ability to compete with larger, including combined, competitors
- 09We may not be able to successfully anticipate consumer trends and demand and our failure to do so may lead to a loss of consumer acceptance of the products we sell
- 10We operate in the highly competitive sleep products industry, and if we are unable to compete successfully, our results of operations could be adversely affected
- 11Our information technology systems may fail to perform adequately, may be disrupted by natural disasters or other catastrophes, or we may be unable to protect the privacy, integrity and security of our information systems
- 12Changes in economic conditions, including the housing market and tariffs, have or will adversely affect our business, results of operations and financial condition
- 13Disruption of our manufacturing has and could increase our costs of doing business or lead to delays in shipping and could materially adversely affect our business, our results of operations, and our financial condition
- 14Future growth and profitability may depend on our ability to improve our product line, successfully introduce new products, and effectively and efficiently market our products to attract and retain customers
- 15Our expansion into wholesale distribution and new sales channels, new products, market segments and geographic regions subjects us to additional business, legal, financial, and competitive risks
- 16Our business could suffer if we are unsuccessful in making, integrating and maintaining commercial agreements, strategic alliances and other business relationships
- 17A reduction in the availability of credit to consumers or the availability of more favorable credit terms with competitors could adversely affect our results of operations and financial condition
- 18Over or under supply of raw material inventory and finished products could leave us vulnerable to shortages or shrinkage that may harm our ability to satisfy consumer demand and could adversely affect our results of operations
- 19If we lose members of the leadership team we may not be able to run our business effectively
Regulatory and Litigation Risks
- 20Regulatory requirements may require costly expenditures and expose us to liability
- 21Regulatory requirements relating to the manufacture and disposal of mattresses may increase our product costs and increase the risk of disruption to our business
- 22We could be subject to additional sales tax or other indirect tax liabilities
- 23Pending or unforeseen litigation and the potential for adverse publicity associated with litigation could adversely affect our business, reputation, results of operations or financial condition
Risks Relating to our Intellectual Property
- 24We may not be able to adequately protect our product designs, brand and other proprietary rights, which could adversely affect our competitive position, reduce the value of our products and brands, and may result in costly litigation to protect our intellectual property rights
- 25We may be subject to claims that we or the licensors of intellectual property rights licensed to us have infringed on proprietary rights, which could require us and our licensors to obtain a license or change designs
- 26We previously licensed certain intellectual property to EdiZONE, LLC (“EdiZONE”), for the purpose of enabling EdiZONE to meet its contractual obligations to licensees. Some of those licensees are competitors and have exclusive rights that we may be required to observe
Risks Relating to our Common Stock
- 27NASDAQ may delist our securities from its exchange, which could harm our business and limit our stockholders’ liquidity
- 28The market price of our Common Stock is volatile and may decline regardless of our results of operations, and Stockholders may not be able to resell shares at or above their purchase price
- 29Significant payment obligations under our Tax Receivable Agreement are accelerated upon a change of control and may discourage the potential acquisition of our Company and adversely affect any potential control premium payable for shares of our Common Stock
- 30Our Second Amended and Restated Certificate of Incorporation could make it very difficult for an investor to bring any legal actions against us, our directors, or our officers and may limit our stockholders’ ability to obtain a favorable judicial forum
- 31Future sales of our Common Stock in the public market may depress our share price
- 32Our stockholders may experience substantial dilution in the value of their investment or may otherwise have their interests impaired if we issue additional debt or equity securities or securities convertible into equity securities, as well as due to the exercise of the currently outstanding Warrants
- 33Our only significant asset is our ownership of Purple LLC and such ownership may not be sufficient to enable us to satisfy our financial obligations
- 34Obligations under the Tax Receivable Agreement could materially adversely affect our future cash flow if we become profitable and begin paying income taxes. Payments under the Tax Receivable Agreement may be accelerated or significantly exceed the actual benefits we realize
- 35Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. Future use and amount of our Current NOLs and other tax benefits is uncertain
- 36The IRS may challenge our Current NOLs and other tax benefits
- 37There is continued risk of ownership change under Code Section 382
- 38The NOL Protective Charter Amendment and the NOL Rights Plan may potentially adversely affect the market for, and negatively impact the value of, our Common Stock
- 39The NOL Protective Charter Amendment and the NOL Rights Plan may have an anti-takeover effect
Other Purple Innovation 10-Ks
- FY2025 10-K risk factors36 risks2 new5 dropped14 reworded
Auditors issued a going concern warning following increased operating losses and negative cash flows.
Filed Mar 31, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.